Literature DB >> 3039389

Detailed analysis of heterogeneity of [3H]naloxone binding sites in rat brain synaptosomes.

M Szücs, A Borsodi, A Bogdány, J Gaál, J Batke, G Tóth.   

Abstract

The experiments reported in this paper address the question of heterogeneity of [3H]naloxone binding sites in rat brainstem synaptosomal preparations at 23 degrees C in the presence of 100 mM sodium chloride. Kinetic analysis in the presence of 0.4, 4 and 10 nM [3H]naloxone gave pseudo-first order association rate of 0.9 +/- 0.04, 1.23 +/- 0.08 and 1.06 +/- 0.08 min-1, respectively. The dissociation of a 1 nM [3H]naloxone receptor complex was biphasic with dissociation rate constants of 1.8 and 0.4 min-1. On the other hand, dissociation of 10 nM [3H]naloxone was monophasic with a kd of 1.1 min-1. Two subpopulations of binding sites were also observed by steady state binding studies, with Kd values of 0.5 and 3.4 nM and a ratio of high to low affinity sites of 1:9. Heterogeneity of [3H]naloxone binding sites could be seen by displacement studies performed with opioid peptides and alkaloids. We suggest that our data best fits a model with two independent naloxone binding sites wherein either one or both undergo a multi-step interaction with ligand.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039389     DOI: 10.1007/BF00971005

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  An improved method for the preparation of synaptosomal fractions in high purity.

Authors:  F Hajós
Journal:  Brain Res       Date:  1975-08-15       Impact factor: 3.252

2.  Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.

Authors:  K J Chang; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

3.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

4.  Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex.

Authors:  L Terenius
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

5.  Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.

Authors:  T H Chiu; D M Dryden; H C Rosenberg
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

6.  Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization.

Authors:  Y Kloog; Y Egozi; M Sokolovsky
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

7.  Demonstration of a slowly dissociating form of bovine hippocampal synaptic membrane opiate receptors.

Authors:  K G Pryhuber; B L Roth; C J Coscia
Journal:  Eur J Pharmacol       Date:  1982-09-10       Impact factor: 4.432

8.  Allosteric coupling between morphine and enkephalin receptors in vitro.

Authors:  R B Rothman; T C Westfall
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

9.  3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone.

Authors:  P Y Law; H H Loh
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-09

10.  Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain.

Authors:  R B Rothman; T C Westfall
Journal:  Eur J Pharmacol       Date:  1981-07-10       Impact factor: 4.432

View more
  2 in total

1.  Selective opioid agonist and antagonist competition for [3H]-naloxone binding in amphibian spinal cord.

Authors:  L C Newman; D R Wallace; C W Stevens
Journal:  Brain Res       Date:  2000-11-24       Impact factor: 3.252

2.  Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding.

Authors:  Q Ni; H Xu; J S Partilla; B R de Costa; K C Rice; A Borsodi; S Hosztafi; R B Rothman
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.